It's Raining FDA Approvals, MSON Muscling Up, RDHL To Report Data In Aug.

01:47 EDT 8 May 2018 | RTTNews

Today's Daily Dose brings you news about FDA approval of Astellas Pharma's Myrbetriq/VESIcare combo for overactive bladder; MediciNova's progress in MN-166 in alcohol dependence and withdrawal; regulatory nod for expanded use of DARZALEX; Ultragenyx Pharma's near-term catalysts; solid financial results of Misonix and Xencor's upcoming clinical trial plans.

It's Raining FDA Approvals, MSON Muscling Up, RDHL To Report Data In Aug.

More From BioPortfolio on "It's Raining FDA Approvals, MSON Muscling Up, RDHL To Report Data In Aug."